Published in J Reprod Immunol on December 01, 1986
Clinical strategies to enhance T cell reconstitution. Semin Immunol (2007) 1.11
Sex, stroke, and inflammation: the potential for estrogen-mediated immunoprotection in stroke. Horm Behav (2012) 0.99
Serum concentrations of 25-OH vitamin D in patients with systemic lupus erythematosus (SLE) are inversely related to disease activity: is it time to routinely supplement patients with SLE with vitamin D? Ann Rheum Dis (2010) 1.52
Presence of prion protein in peripheral tissues of Libyan Jews with Creutzfeldt-Jakob disease. Neurology (1992) 1.52
Cerebrospinal cytokine levels in patients with acute depression. Neuropsychobiology (1999) 1.49
Prostanoid synthesis by cultured intestinal epithelial and mononuclear cells in inflammatory bowel disease. Gut (1983) 1.42
Screening for prostate cancer. Isr J Med Sci (1995) 1.38
Heparin-like molecules bind differentially to prion-proteins and change their intracellular metabolic fate. J Cell Physiol (1993) 1.26
Protection against endotoxic shock and lipopolysaccharide-induced local inflammation by tetracycline: correlation with inhibition of cytokine secretion. Infect Immun (1996) 1.24
The anti-prion activity of Congo red. Putative mechanism. J Biol Chem (1998) 1.23
Capacity of thymic cells to effect target cell lysis following treatment with concanavalin A. Cell Immunol (1972) 1.20
Vitamin D: an instrumental factor in the anti-phospholipid syndrome by inhibition of tissue factor expression. Ann Rheum Dis (2010) 1.15
The secretion of PGE2, IL-1 beta, IL-6, and TNF alpha by adherent mononuclear cells from early onset periodontitis patients. J Periodontol (1994) 1.13
A protease-resistant prion protein isoform is present in urine of animals and humans affected with prion diseases. J Biol Chem (2001) 1.13
Enhancing T lymphocytes from tumor-bearing mice suppress host resistance to a syngeneic tumor. Eur J Immunol (1974) 1.13
Constitutive secretion of interleukin 1 by human monocytes. Eur J Immunol (1983) 1.12
Markedly elevated levels of vascular endothelial growth factor, fibroblast growth factor, and interleukin 6 in Meigs syndrome. Am J Obstet Gynecol (2001) 1.12
The isolation and purification of human peripheral blood monocytes in cell suspension. J Immunol Methods (1980) 1.08
Insoluble wild-type and protease-resistant mutant prion protein in brains of patients with inherited prion disease. Nat Med (1996) 1.08
Elevated serum levels of soluble tumour necrosis factor receptors (sTNF-R) in patients with HIV infection. Clin Exp Immunol (1992) 1.05
Prostanoid synthesis by cultured peripheral blood mononuclear cells in inflammatory diseases of the bowel. Gastroenterology (1982) 1.05
Clinical diagnosis of secondary tumors of the heart and pericardium. Dis Chest (1969) 1.00
Identification of interleukin-2 in human peripheral blood eosinophils. Immunology (1996) 0.99
Systemic administration of doxorubicin-containing liposomes in cancer patients: a phase I study. Eur J Cancer Clin Oncol (1989) 0.98
Plasma inflammatory cytokines correlate to the ovarian hyperstimulation syndrome. Hum Reprod (1996) 0.98
Vascular endothelial growth factor plasma levels correlate to the clinical picture in severe ovarian hyperstimulation syndrome. Fertil Steril (1997) 0.97
Antitumor and immunotherapeutic effects of activated invasive T lymphoma cells that display short-term interleukin 1alpha expression. Cancer Res (1999) 0.97
Prognostic role of serum cytokeratin 19 fragments in advanced non-small-cell lung cancer: association of marker changes after two chemotherapy cycles with different measures of clinical response and survival. Br J Cancer (2007) 0.95
Activation of murine macrophages by lipoprotein and lipooligosaccharide of Treponema denticola. Infect Immun (1999) 0.95
Characterization of intraperitoneal cytokines and nitrites in women with severe ovarian hyperstimulation syndrome. Fertil Steril (1996) 0.94
5-Fluorouracil, doxorubicin (adriamycin) and mitomycin-C (FAM) in advanced gastric cancer: observations on response, patient characteristics, myelosuppression and delivered dosage. Oncology (1989) 0.92
Immunotherapy of lethal metastases by lymphocytes sensitized against tumor cells in vitro. J Natl Cancer Inst (1975) 0.91
Therapeutic irradiation of the chest and electrocardiographic changes. Clin Radiol (1969) 0.91
Interleukin-1 activity in lesioned peripheral nerve. J Neuroimmunol (1992) 0.90
A new human ovarian carcinoma cell line: establishment and analysis of tumor-associated markers. Oncology (1985) 0.90
A rare case of intramedullary cervical spinal cord meningioma and review of the literature. Spinal Cord (2008) 0.89
[Solitary metastatic involvement of the spleen in squamous cell carcinoma of the cervix]. Harefuah (1977) 0.89
A syngeneic metastatic tumor model in mice: the natural immune response of the host and its manipulation. Isr J Med Sci (1976) 0.89
Establishment of cell lines from somatic cell hybrids between human monocytes and mouse myeloma cells. J Immunol (1984) 0.89
Prion protein with an E200K mutation displays properties similar to those of the cellular isoform PrP(C). J Neurochem (2001) 0.88
The management of pericardial effusion in cancer patients. Chest (1977) 0.88
High-density lipoprotein and extracellular matrix promotes growth and plating efficiency of normal human mammary epithelial cells in serum-free medium. Int J Cancer (1983) 0.87
Selection and continuous growth of antigen-specific human T cells by antigen-treated monocytes. Eur J Immunol (1983) 0.87
The mechanism of human bladder tumor implantation in an in vitro model. J Urol (1986) 0.87
Cerebrospinal fluid soluble interleukin-2 receptor in cerebral lupus. Br J Rheumatol (1997) 0.86
High oxygen concentration exacerbates cardiopulmonary bypass-induced lung injury. J Cardiothorac Vasc Anesth (2000) 0.86
Isolated pericardial metastasis of parotid tumor origin. Head Neck Surg (1982) 0.85
The effects of respiratory muscle training on improvement of the internal and external thoraco-pulmonary respiratory mechanism in COPD patients. Ann Phys Rehabil Med (2013) 0.85
Plasma vascular endothelial growth factor level is a predictor of the severity of postoperative capillary leak syndrome in neonates undergoing cardiopulmonary bypass. Pediatr Surg Int (2002) 0.85
Ciprofloxacin immunomodulation of experimental antiphospholipid syndrome associated with elevation of interleukin-3 and granulocyte-macrophage colony-stimulating factor expression. Arthritis Rheum (1998) 0.84
Serum levels of interleukin-2 receptor in ocular Behçet's disease. Am J Ophthalmol (1993) 0.84
Effect of beta-blocking drug propranolol on 131 I utilization in euthyroid patients. J Clin Pharmacol New Drugs (1972) 0.84
Primary cultures of human spleen macrophages in vitro. J Immunol Methods (1976) 0.84
Repeat bacterial challenge in a subcutaneous chamber model results in augmented tumour necrosis factor-alpha and interferon-gamma response, and suppression of interleukin-10. Immunology (2000) 0.84
Perception of ill spouse and dyadic relationship in couples with affective disorder and those without. J Affect Disord (2000) 0.84
Rapid fluorometric quantification of monocyte attachment in tissue culture wells. J Immunol Methods (1993) 0.83
Effects of tetracyclines on the pathologic activity of endotoxin: in vitro and in vivo studies. Adv Dent Res (1998) 0.83
Recombinant human interleukin-1 suppresses lipoprotein lipase activity, but not expression of lipoprotein lipase mRNA in mesenchymal rat heart cell cultures. Biochim Biophys Acta (1991) 0.83
Metastatic bone involvement in gynecological malignancies. Radiol Clin (Basel) (1978) 0.83
Monoclonal anti-endothelial cell antibodies from a patient with Takayasu arteritis activate endothelial cells from large vessels. Arthritis Rheum (1999) 0.83
Copper binding to the PrP isoforms: a putative marker of their conformation and function. J Virol (2001) 0.83
Increased serum concentrations of interleukin-1 beta in patients with coronary artery disease. Heart (1996) 0.83
Spontaneous pneumothorax complicating lung metastases from carcinoma of the breast. Radiol Clin (Basel) (1977) 0.83
Detection of 14-3-3 protein in the CSF of genetic Creutzfeldt-Jakob disease. Neurology (1997) 0.82
Increased levels of basic fibroblast growth factor are found in the cross-clamped heart during cardiopulmonary bypass. Can J Cardiol (2000) 0.82
Ex vivo expansion of CD56+ cytotoxic cells from human umbilical cord blood. Exp Hematol (2001) 0.82
Human monocyte response to cementum extracts from periodontally diseased teeth: effect of conditioning with tetracycline. J Periodontol (1996) 0.82
Episodic angioedema with eosinophilia: a case associated with T cell activation and cytokine production. Ann Allergy (1993) 0.82
Serum basic fibroblast growth factor levels in patients with ischemic heart disease. Int J Cardiol (1997) 0.82
Interleukin-18 binding protein in acute graft versus host disease and engraftment following allogeneic peripheral blood stem cell transplants. J Hematother Stem Cell Res (2001) 0.82
Suppressor factor secreted by T-lymphocytes from tumor-bearing mice. J Natl Cancer Inst (1976) 0.82
Thyroid carcinoma induced by irradiation for Hodgkin's disease. Report of a case. Acta Radiol Oncol Radiat Phys Biol (1978) 0.81
Breast cancer arising in surgical scars. J Surg Oncol (1976) 0.81
Soluble ICAM-1 and E-selectin levels correlate with clinical and biological aspects of severe ovarian hyperstimulation syndrome. Fertil Steril (2001) 0.81
Parameters affecting the in vitro maturation of human monocytes to macrophages. Int J Cell Cloning (1986) 0.81
Interleukin 1 inhibitory activity secreted by a human myelomonocytic cell line (M20). Eur J Immunol (1986) 0.81
Transition from T cell protection to T cell enhancement during tumor growth in an allogeneic host. Transplantation (1976) 0.81
Levels of cytokines and collagen type I and type III as a function of age in human gingivitis. J Periodontol (1996) 0.81
In vivo effects of lymphocytes sensitized in vitro against tumor cells. Ann N Y Acad Sci (1976) 0.80
Differential allelic expression of PrP mRNA in carriers of the E200K mutation. Neurology (1997) 0.80
CA-125 is present in significant concentrations in periovulatory follicles of in vitro fertilization patients. Fertil Steril (1992) 0.80
The carcinomatous neuropathy. A clinical and electro-physiological comparative study, with special reference to the effect of treatment on the nervous system. Eur Neurol (1970) 0.80
Tetracycline inhibits Porphyromonas gingivalis lipopolysaccharide-induced lesions in vivo and TNF alpha processing in vitro. J Periodontal Res (1997) 0.80
Serum amyloid P-component levels in patients with malignancy. Scand J Immunol (1986) 0.80
Histamine enhances granulocyte-macrophage colony-stimulating factor and interleukin-6 production by human peripheral blood mononuclear cells. J Leukoc Biol (1995) 0.80
Anti-idiotype immunomodulation of experimental anti-phospholipid syndrome via effect on Th1/Th2 expression. Clin Exp Immunol (1999) 0.80
In vitro induction of cell-mediated immunity against tumor cells by antigen-fed macrophages. Immunol Rev (1978) 0.80
Familial nephritis. Isr J Med Sci (1967) 0.80
Antigen presentation and regulatory functions of human monocytes in the in vitro response of lymphocytes against purified protein derivative of tuberculin (PPD). Eur J Immunol (1981) 0.80
Interleukin-1 favours the in vitro development of type 2 T helper (Th2) human T-cell clones. Res Immunol (1994) 0.80
Toxicology and antitumor activity of tuftsin. Ann N Y Acad Sci (1983) 0.80